Bartova L

Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Vienna, Austria.

7 papers · ORCID

ArticleKetamine

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: Data from the enTRD registry.

Preiss M, Popper V, Faber LHC +8

Europe PMC2026
ArticleKetamine

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Young AH, Bartova L, Cardoner N +9

Europe PMC2026
ArticleKetamine

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.

Diendorfer CM, Bum C, Weidenauer A +7

Europe PMC2026
ArticleKetamine

Esketamine in persistent long COVID with predominant psychiatric manifestations: A case series

Bozic I, Ivkic D, Reinfried L +11

Europe PMC2025
ArticleKetamine

The role of esketamine in persistent long COVID with predominant psychiatric manifestations.

Bozic I, Ivkic D, Reinfried L +11

Europe PMC2025
ArticleKetamine

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders - volume II.

Hartelius G, Muscat SA, Bartova L

Europe PMC2024
ArticleKetamine

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders.

Hartelius G, Muscat SA, Bartova L

Europe PMC2023